Phase II Study of Gemcitabine, Carboplatin, and Bevacizumab in Patients With Advanced Unresectable or Metastatic Urothelial Cancer

PURPOSE: Although gemcitabine and carboplatin (GCa) is a standard option for patients with advanced urothelial cancer (UC) who are ineligible for cisplatin, outcomes remain poor. This trial evaluated the efficacy and safety of bevacizumab with GCa in advanced UC. PATIENTS AND METHODS: Patients with...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Balar, Arjun V., Apolo, Andrea B., Ostrovnaya, Irina, Mironov, Svetlana, Iasonos, Alexia, Trout, Alisa, Regazzi, Ashley M., Garcia-Grossman, Ilana R., Gallagher, David J., Milowsky, Matthew I., Bajorin, Dean F.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2013
Matèries:
Original Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3574268/
https://ncbi.nlm.nih.gov/pubmed/23341513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.42.5215
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars